Plain-English translation of NCT06537258 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new supportive care program for teenagers ages 13–18 who have inflammatory bowel disease and are also experiencing depression or anxiety. The program teaches coping skills and uses heart rate biofeedback—a technique that shows you your own heart's patterns in real time—to help you calm your nervous system. Researchers believe that by learning to control your stress response, you may feel better emotionally and experience fewer disease symptoms.
Many teenagers with inflammatory bowel disease struggle with anxiety and depression, which can make their physical symptoms worse. This trial exists because doctors believe that the stress and anxiety may be partly controlled by the nervous system's automatic responses, and helping teens learn to manage those responses could improve both their emotional health and their disease control.
You likely qualify if…
You likely don't qualify if…
If you join, you'll attend 4 in-person visits at the clinic (about 1 hour each) and participate in 6 weekly online group sessions (about 45 minutes each) over 6 weeks, where you'll learn coping skills and use heart rate biofeedback with a small group of 5–8 other teens. You'll also complete surveys, have blood and stool samples collected, and wear a device that measures your heart rate patterns. The entire study lasts 7 months, with follow-up assessments at 6 weeks, 14 weeks, and 26 weeks to see how you're doing. If you're randomly assigned to the wait-list control group, you'll complete assessments first and then begin the same treatment program later.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States